CXCL16 and acute respiratory distress syndrome: In conclusion, our study confirms the important contribution of RAGE and Ang-2 and supports the novel inclusion of CXCL16, together with the clinical marker PaO2/FiO2, to build a panel with good ARDS prediction among septic patients.